University of Tennessee-Memphis

Memphis, Tennessee 38163-2116

1 studies enrolling now · 17 studies all time

What they study most

Adenocarcinoma of the Rectum, Autoimmune Diseases, Breast Cancer, Colorectal Cancer, Depression, Esophageal Cancer, Extensive Stage Small Cell Lung Cancer, Hemorrhagic Shock, Huntington Disease, Immunologic Diseases, Lupus Glomerulonephritis, Lupus Nephritis

Studies at this site

• A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer — Recruiting now
• A Study of SHP655 (rADAMTS13) in Sickle Cell Disease — Completed
• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer — Stopped early
• S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Positron Emission Tomography in Determining Stage of Esophageal Cancer — Completed
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy — Stopped early
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Status unconfirmed
• Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma — Completed
• Oral Collagen for Rheumatoid Arthritis — Completed
• Study of Antidepressants in Parkinson's Disease — Completed
• Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer — Completed
• Cooperative Huntington's Observational Research Trial — Status unconfirmed
• Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis — Completed
• A Longitudinal Observational Follow-up of the PRECEPT Study Cohort — Status unconfirmed
• TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease — Completed
• Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease — Completed
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting — Status unconfirmed